Brenus Pharma Announces First Patients Dosed in its First-in-Human Trial Evaluating STC-1010, a Next-Generation Immunotherapy

businesswire

Brenus Pharma Announces First Patients Dosed in its First-in-Human Trial Evaluating STC-1010, a Next-Generation Immunotherapy – NEWSnet – News… as it used to be

More Press Releases

April 29, 2026

WorkFusion, a UiPath Company, Ranked #5 in Everest Group’s Top 50™ Financial Crime and Compliance (FCC) Technology Providers 2026

April 29, 2026

/C O R R E C T I O N — Barker Wellness/

April 29, 2026

EquipmentShare to Present at the Oppenheimer 21st Annual Industrial Growth Conference

April 29, 2026

Brenus Pharma Announces First Patients Dosed in its First-in-Human Trial Evaluating STC-1010, a Next-Generation Immunotherapy

WorkFusion, a UiPath Company, Ranked #5 in Everest Group’s Top 50™ Financial Crime and Compliance (FCC) Technology Providers 2026

/C O R R E C T I O N — Barker Wellness/

EquipmentShare to Present at the Oppenheimer 21st Annual Industrial Growth Conference

Hawthorn Bancshares Announces Cash Dividend